CN Stock MarketDetailed Quotes

603983 Guangdong Marubi Biotechnology

Watchlist
  • 27.68
  • -1.26-4.35%
Not Open Nov 22 15:00 CST
11.10BMarket Cap34.22P/E (TTM)

About Guangdong Marubi Biotechnology Company

The company was registered and established in the Luogang Branch of the Guangzhou Administration for Industry and Commerce on April 2, 2002. The company is mainly engaged in R&D, design, production, sales and service of various cosmetics based on dermatology and biological research. Its main brands are “Marumi,” “Koibi,” and “Haruki.” In 2023, the company received additional honorary qualifications such as “Specialized, Special and New” Enterprise in Guangdong Province and Guangdong Industrial Design Center.

Company Profile

Short Name-A丸美股份
Symbol-A603983
Company NameGuangdong Marubi Biotechnology Co., Ltd.
Listing DateJul 25, 2019
Issue Price20.54
Shares Offered41.00M share(s)
FoundedApr 2, 2002
Listed ExchangeSH Stock Exchange
Legal Representativehuaiqing sun
General Managerhuaiqing sun
Secretarydi cheng
Accounting FirmHuaxing Certified Public Accountants Firm (Special General Partnership)
Securities Representativeyunxin tan
Legal CounselGuangdong Cinda Law Firm
Employees140
Phone020-66378685
Office Address6th Floor, South Tower, Poly Wei Tower, No. 11 Xiancun Road, Zhujiang New Town, Tianhe District, Guangzhou
Zip Code510000
Registered AddressBuilding 2, No. 92, Banhe Road, Science City, Guangzhou High-tech Industrial Development Zone, Guangdong
Fax020-66378600
Emailsecurities@marubi.cn
Websitehttp://www.marubi.cn
Business License533423600000496
BusinessCosmetics manufacturing; cosmetics and hygiene products wholesale; cosmetics and hygiene products retail; biotechnology development services (China's rare and unique precious varieties, except for the development of wild animals and plant resources protected by the country); biotechnology consulting and exchange services (with the exception of China's rare and endemic precious and excellent varieties, nationally protected wildlife and plant resource development native to China); biotechnology promotion services (excluding China's rare and unique precious and excellent varieties, nationally protected wildlife and plant resource development originating in China); biotechnology transfer services (except for China's rare and endemic species, nationally protected wildlife and plant resource development originating in China); biotechnology transfer services (excluding China's rare and endemic species, nationally protected wildlife and plant resource development originating in China); biotechnology transfer services (except for China's rare and endemic species native to China); biotechnology transfer services (except for China's rare and endemic species, nationally protected wildlife and plant resource development originating in China); biotechnology transfer services (excluding China's rare and endemic species, nationally protected wildlife and plant resource development originating in China); biotechnology transfer services (with the exception of biotechnology transfer services country Rare and unique precious and excellent varieties, protected by the country, excluding the development of wild animals and plant resources in China; food science and technology research services; import and export of goods (with the exception of goods involving special regulations and license approval for foreign investment access); technology import and export; wholesale trade of goods (except for goods involving special management regulations and license approval for foreign investment access); retail trade of goods (except for goods involving special regulations and license approval for foreign investment access); unauthorized medical device management; pre-packaged food wholesale; pre-packaged food retail.

Company Executives

  • Name
  • Position
  • Salary
  • huaiqing sun
  • Chairman, Directors, General Manager, CEOs, Strategy Committee Convener
  • 2.11M
  • yunqi sun
  • Directors, Nomination Committee Members
  • 600.30K
  • lingchun ceng
  • directors, Chief Marketing Officer (CMO), Strategy Committee Member
  • 2.08M
  • kaihui wang
  • directors, Chief Financial Officer (CFO), Remuneration and Assessment Committee Next
  • 2.31M
  • yi shen
  • Directors, Audit Committee Member
  • 1.04M
  • chaowan guo
  • Directors
  • 832.00K
  • qixiang zhang
  • Independent Directors, Audit Committee Member, Nomination Committee Convener
  • --
  • yong cao
  • Independent Directors, Remuneration and Assessment Committee Convener, Strategy Committee Member, Nomination Committee Members
  • 58.30K
  • youying ou
  • Independent Directors, Audit Committee Convener, Member of the Remuneration and Assessment Committee
  • --
  • di cheng
  • Board Secretary
  • 619.20K
  • yunxin tan
  • Securities Affairs Representative
  • --
  • qingmei chen
  • Chairman of the Supervisory Board, Employee Supervisors
  • 344.40K
  • huanqiu liang
  • Shareholder Supervisors
  • 390.30K
  • jiayang chen
  • Shareholder Supervisors
  • 310.70K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data